Pharmacological management of adult patients with acute respiratory distress syndrome

References

• Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–323.
   PubMed Web of Science ®Google Scholar
• Murray JF, Matthay MA, Luce JM, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–723.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–824.
   PubMed Web of Science ®Google Scholar
• Ferguson ND, Frutos-Vivar F, Esteban A, et al. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med. 2005;33(10):2228–2234.
   PubMed Web of Science ®Google Scholar
• ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.
   PubMed Web of Science ®Google Scholar
• Villar J, Zhang H, Slutsky AS. Lung repair and regeneration in ARDS: role of PECAM1 and Wnt signaling. Chest. 2019;155(3):587–594.
   PubMed Web of Science ®Google Scholar
• Tisoncik JR, Korth MJ, Simmons CP, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.
   PubMed Web of Science ®Google Scholar
• Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(6):562–572.
   PubMed Web of Science ®Google Scholar
• Dries DJ. Acute respiratory distress syndrome and lung protection. Air Med J. 2016;35(2):59–62.
   PubMedGoogle Scholar
• Tonelli AR, Zein J, Adams J, et al. Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med. 2014;40(6):769–787.
   PubMed Web of Science ®Google Scholar
• Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126–2136.
   PubMed Web of Science ®Google Scholar
• Abrams D, Schmidt M, Pham T, et al. Mechanical ventilation for acute respiratory distress syndrome during extracorporeal life support. Research and practice. Am J Respir Crit Care Med. 2020;201(5):514–525.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.
   PubMed Web of Science ®Google Scholar
• Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016;388(10058):2416–2430.
   PubMed Web of Science ®Google Scholar
• Hager DN. Recent advances in the management of the acute respiratory distress syndrome. Clin Chest Med. 2015;36(3):481–496.
   PubMed Web of Science ®Google Scholar
• Villar J, Kacmarek RM, Guérin C. Clinical trials in patients with the acute respiratory distress syndrome: burn after reading. Intensive Care Med. 2014;40(6):900–902.
   PubMed Web of Science ®Google Scholar
• Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–1116.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Moss M, Huang DT, Brower RG, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 2019;380(21):1997–2008.
   PubMed Web of Science ®Google Scholar
• Ho ATN, Patolia S, Guervilly C. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. J Intensive Care. 2020;8:12.
   PubMed Web of Science ®Google Scholar
• Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000;21(3):435–466.
   PubMed Web of Science ®Google Scholar
• Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276.
   PubMed Web of Science ®Google Scholar
• Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.
   PubMed Web of Science ®Google Scholar
• Tang BM, Craig JC, Eslick GD, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37(5):1594–1603.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Lin HH, Huang CT, et al. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2014;18(2):R63.
   PubMed Web of Science ®Google Scholar
• Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–1684.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Bridges L, Shih MC, et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829–840.
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Richard JC, Mercat A, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011;183(9):1200–1206.
   PubMed Web of Science ®Google Scholar
• Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11(4):345–354.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fu X, Liu X, et al. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep. 2020;10(1):3044.
   PubMed Web of Science ®Google Scholar
• Mammen MJ, Aryal K, Alhazzani W, et al. Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. Pol Arch Intern Med. 2020;130(4):276–286.
   PubMedGoogle Scholar
• Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43(12):1751–1763.
   PubMed Web of Science ®Google Scholar
• Kido T, Muramatsu K, Asakawa T, et al. The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan. BMC Pulm Med. 2018;18(1):28.
   PubMedGoogle Scholar
• Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6(1):e000420.
   PubMed Web of Science ®Google Scholar
• Terblanche M, Almog Y, Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7(5):358–368.
   PubMed Web of Science ®Google Scholar
• Kruger PS, Venkatesh B. Are there any benefits from statin treatment for the septic patient? Curr Atheroscler Rep. 2014;16(1):378.
   PubMed Web of Science ®Google Scholar
• Jacobson JR, Barnard JW, Grigoryev DN, et al. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288(6):L1026–L1032.
   PubMed Web of Science ®Google Scholar
• Altintas ND, Atilla P, Iskit AB, et al. Long-term simvastatin attenuates lung injury and oxidative stress in murine acute lung injury models induced by oleic acid and endotoxin. Respir Care. 2011;56(8):1156–1163.
   PubMed Web of Science ®Google Scholar
• Craig TR, Duffy MJ, Shyamsundar M, et al. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2011;183(5):620–626.
   PubMed Web of Science ®Google Scholar
• McAuley DF, Laffey JG, O’Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371(18):1695–1703.
   PubMed Web of Science ®Google Scholar
• Agus A, Hulme C, Verghis RM, et al. Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial. Crit Care. 2017;21(1):108.
   PubMedGoogle Scholar
• Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301–1308.
   PubMed Web of Science ®Google Scholar
• Shen Y, Cai G, Gong S, et al. Interaction between low tidal volume ventilation strategy and severity of acute respiratory distress syndrome: a retrospective cohort study. Crit Care. 2019;23(1):254.
   PubMedGoogle Scholar
• National Heart, Lung, and Blood Institute ARDS Clinical Trials Network; Truwit JD, Bernard GR, Steingrub J, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014;370(23):2191–2200.
   PubMed Web of Science ®Google Scholar
• Dinglas VD, Hopkins RO, Wozniak AW, et al. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. Thorax. 2016;71(5):401–410.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691–698.
   PubMed Web of Science ®Google Scholar
• Sinha P, Delucchi KL, Thompson BT, et al. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018;44(11):1859–1869.
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee MG, Hsu TC, et al. A population-based cohort study on the drug-specific effect of statins on sepsis outcome. Chest. 2018;153(4):805–815.
   PubMed Web of Science ®Google Scholar
• Kruger PS, Terblanche M. Statins in patients with sepsis and ARDS: is it over? No. Intensive Care Med. 2017;43(5):675–676.
   PubMed Web of Science ®Google Scholar
• Nagendran M, McAuley DF, Kruger PS, et al. Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials. Intensive Care Med. 2017;43(5):663–671.
   PubMed Web of Science ®Google Scholar
• Lewis SR, Pritchard MW, Thomas CM, et al. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019;7(7):CD004477.
   PubMedGoogle Scholar
• Teran Plasencia J, Chacon A, Garnet B, et al. Statin therapy prior to septic shock is associated with a reduced risk of ARDS [abstract]. Chest. 2019;156(4):A976.
   Web of Science ®Google Scholar
• Kempker JA, Tangpricha V, Ziegler TR, et al. Vitamin D in sepsis: from basic science to clinical impact. Crit Care. 2012;16(4):316.
   PubMed Web of Science ®Google Scholar
• Dancer RC, Parekh D, Lax S, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax. 2015;70(7):617–624.
   PubMed Web of Science ®Google Scholar
• Viglianti EM, Zajic P, Iwashyna TJ, et al. Neither vitamin D levels nor supplementation are associated with the development of persistent critical illness: a retrospective cohort analysis. Crit Care Resusc. 2019;21(1):39–44.
   PubMed Web of Science ®Google Scholar
• Putzu A, Belletti A, Cassina T, et al. Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials. J Crit Care. 2017;38:109–114.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Ginde AA, Brower RG, Caterino JM, et al. Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients. N Engl J Med. 2019; 381(26):2529–2540.
   PubMed Web of Science ®Google Scholar
• Zemans RL. Acute respiratory distress syndrome. In: Sidhaye VK, Koval M, editors. Lung epithelial biology in the pathogenesis of pulmonary disease. Academic Press; 2017. p. 185–209.
   Google Scholar
• Quinlan GJ, Lamb NJ, Tilley R, et al. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med. 1997;155(2):479‐484.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Page C, et al. Thiol-based drugs in pulmonary medicine: much more than mucolytics. Trends Pharmacol Sci. 2019;40(7):452–463.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Lucht WD, Niedermeyer ME, et al. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest. 1984;73(6):1772–1784.
   PubMed Web of Science ®Google Scholar
• Suter PM, Domenighetti G, Schaller MD, et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994;105(1):190–194.
   PubMed Web of Science ®Google Scholar
• Jepsen S, Herlevsen P, Knudsen P, et al. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med. 1992;20(7):918–923.
   PubMed Web of Science ®Google Scholar
• Lu X, Ma Y, He J, et al. N-acetylcysteine for adults with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Hong Kong J Emerg Med. 2019;26(5):288–298.
   Web of Science ®Google Scholar
• Koekkoek WA, van Zanten AR. Antioxidant vitamins and trace elements in critical illness. Nutr Clin Pract. 2016;31(4):457–474.
   PubMed Web of Science ®Google Scholar
• May JM, Qu ZC, Meredith ME. Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells. Biochem Biophys Res Commun. 2012;426(1):148–152.
   PubMed Web of Science ®Google Scholar
• Ströhle A, Hahn A. Vitamin C and immune function. Med Monatsschr Pharm. 2009;32(2):49–54.
   PubMedGoogle Scholar
• Wang Y, Lin H, Lin BW, et al. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Ann Intensive Care. 2019;9(1):58.
   PubMedGoogle Scholar
• Fowler III AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular Injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261–1270.
   PubMed Web of Science ®Google Scholar
• Chang P, Liao Y, Guan J, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock (HYVCTTSSS): A randomized controlled clinical trial. Chest. 2020. DOI:10.1016/j.chest.2020.02.065.
   Web of Science ®Google Scholar
• Xu CE, Zhang MY, Zou CW, et al. Evaluation of the pharmacological function of ulinastatin in experimental animals. Molecules. 2012;17(8):9070–9080.
   PubMed Web of Science ®Google Scholar
• Xu Q, Yan Q, Chen S. Ulinastatin is effective in reducing mortality for critically ill patients with sepsis: a causal mediation analysis. Sci Rep. 2018;8(1):14360.
   PubMedGoogle Scholar
• Ji M, Chen T, Wang B, et al. Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS. Exp Ther Med. 2018;15(6):4665–4670.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu Z, Jiao W, et al. Ulinastatin treatment for acute respiratory distress syndrome in China: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19(1):196.
   PubMed Web of Science ®Google Scholar
• Ozolina A, Sarkele M, Sabelnikovs O, et al. Activation of coagulation and fibrinolysis in acute respiratory distress syndrome: a prospective pilot study. Front Med (Lausanne). 2016;3:64.
   PubMed Web of Science ®Google Scholar
• Washington AV, Esponda O, Gibson A. Platelet biology of the rapidly failing lung. Br J Haematol. 2020;188(5):641–651.
   PubMed Web of Science ®Google Scholar
• Lefrançais E, Ortiz-Muñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544(7648):105–109.
   PubMed Web of Science ®Google Scholar
• Nguyen Q, Shiva S. Platelets: lone rangers of inflammatory signaling in the lung. Am J Respir Cell Mol Biol. 2019;61(2):139–140.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Ley K. The role of platelets in acute lung injury (ALI). Front Biosci (Landmark Ed). 2009;14:150–158.
   PubMed Web of Science ®Google Scholar
• Ortiz-Diaz E, Festic E, Gajic O, et al. Emerging pharmacological therapies for prevention and early treatment of acute lung injury. Semin Respir Crit Care Med. 2013;34(4):448–458.
   PubMed Web of Science ®Google Scholar
• Aranda-Valderrama P, Kaynar AM. The basic science and molecular mechanisms of lung injury and acute respiratory distress syndrome. Int Anesthesiol Clin. 2018;56(1):1–25.
   PubMed Web of Science ®Google Scholar
• Bastarache JA, Wang L, Geiser T, et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax. 2007;62(7):608–616.
   PubMed Web of Science ®Google Scholar
• Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986–1000.
   PubMed Web of Science ®Google Scholar
• Erlich JM, Talmor DS, Cartin-Ceba R, et al. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest. 2011;139(2):289–295.
   PubMed Web of Science ®Google Scholar
• Kor DJ, Erlich J, Gong MN, et al. Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med. 2011;39(11):2393–2400.
   PubMed Web of Science ®Google Scholar
• Chen W, Janz DR, Bastarache JA, et al. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med. 2015;43(4):801–807.
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Di Gangi S, Hamid UI, et al. Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care. 2015;19:109.
   PubMed Web of Science ®Google Scholar
• Abdulnour RE, Gunderson T, Barkas I, et al. Early intravascular events are associated with development of acute respiratory distress syndrome. A substudy of the LIPS-A clinical trial. Am J Respir Crit Care Med. 2018;197(12):1575–1585.
   PubMed Web of Science ®Google Scholar
• Kor DJ, Carter RE, Park PK, et al. Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: the LIPS-A randomized clinical trial. JAMA. 2016;315(22):2406–2414.
   PubMed Web of Science ®Google Scholar
• Yu H, Ni YN, Liang ZA, et al. The effect of aspirin in preventing the acute respiratory distress syndrome/acute lung injury: A meta-analysis. Am J Emerg Med. 2018;36(8):1486–1491.
   PubMed Web of Science ®Google Scholar
• Jin W, Chuang CC, Jin H, et al. Effects of pre-hospital antiplatelet therapy on the incidence of ARDS. Respir Care. 2020;65(7):1039-1045.
   Web of Science ®Google Scholar
• Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437–444.
   PubMed Web of Science ®Google Scholar
• Camprubí-Rimblas M, Guillamat-Prats R, Lebouvier T, et al. Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury. Respir Res. 2017;18(1):89.
   PubMedGoogle Scholar
• Chimenti L, Camprubí-Rimblas M, Guillamat-Prats R, et al. Nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury. Thromb Haemost. 2017;117(11):2125–2134.
   PubMed Web of Science ®Google Scholar
• Juschten J, Tuinman PR, Juffermans NP, et al. Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies. Ann Transl Med. 2017;5(22):444.
   PubMed Web of Science ®Google Scholar
• Bandeshe H, Boots R, Dulhunty J, et al. Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients?: the IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group. J Crit Care. 2016;34:95‐102.
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Yang B, et al. Low-molecular-weight heparin treatment for acute lung injury/acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. Int J Clin Exp Med. 2018;11(2):414–422.
   Web of Science ®Google Scholar
• Abdelaal Ahmed Mahmoud A, Mahmoud HE, Mahran MA, et al. Streptokinase versus unfractionated heparin nebulization in patients with severe acute respiratory distress syndrome (ARDS): a randomized controlled trial with observational controls. J Cardiothorac Vasc Anesth. 2020;34(2):436–443.
   PubMed Web of Science ®Google Scholar
• Repessé X, Charron C, Vieillard-Baron A. Acute cor pulmonale in ARDS: rationale for protecting the right ventricle. Chest. 2015;147(1):259–265.
   PubMed Web of Science ®Google Scholar
• Yu B, Ichinose F, Bloch DB, et al. Inhaled nitric oxide. Br J Pharmacol. 2019;176(2):246–255.
   PubMed Web of Science ®Google Scholar
• Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology. 1995;83(1):56–65.
   PubMed Web of Science ®Google Scholar
• Kass LJ, Apkon M. Inhaled nitric oxide in the treatment of hypoxemic respiratory failure. Curr Opin Pediatr. 1998;10(3):284–290.
   PubMedGoogle Scholar
• Afshari A, Brok J, Møller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev. 2010;7:CD002787.
   Google Scholar
• Adhikari NK, Dellinger RP, Lundin S, et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med. 2014;42(2):404–412.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Huang TM, Wu HY, et al. Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trials. Crit Care. 2015;19(1):137.
   PubMedGoogle Scholar
• Angus DC, Clermont G, Linde-Zwirble WT, et al. Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med. 2006;34(12):2883–2890.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Trzeciak SW, Criner GJ, et al. Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome. Crit Care. 2012;16(2):R36.
   PubMed Web of Science ®Google Scholar
• Gebistorf F, Karam O, Wetterslev J, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016;2016(6):CD002787.
   Google Scholar
• Papazian L, Aubron C, Brochard L, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):69.
   PubMedGoogle Scholar
• Searcy RJ, Morales JR, Ferreira JA, et al. The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Ther Adv Respir Dis. 2015;9(6):302–312.
   PubMed Web of Science ®Google Scholar
• Pacheco J, Arnold H, Skrupky L, et al. Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol. Respir Care. 2014;59(8):1178–1185.
   PubMed Web of Science ®Google Scholar
• Afshari A, Bastholm Bille A, Allingstrup M. Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS). Cochrane Database Syst Rev. 2017;7(7):CD007733.
   PubMedGoogle Scholar
• Viau-Lapointe J, Fan E. COUNTERPOINT: does persistent or worsening ARDS refractory to optimized ventilation and proning deserve a trial of prostacyclin? No. Chest. 2019;155(4):665–668.
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Salahuddin N, Zubair S, et al. Use of inhaled PGE1 to improve diastolic dysfunction, LVEDP, pulmonary hypertension and hypoxia in ARDS - A randomised clinical trial. Open J Anesth. 2013;3(2):109–115.
   Google Scholar
• Fuller BM, Mohr NM, Skrupky L, et al. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest. 2015;147(6):1510–1522.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(6):1376–1383.
   PubMed Web of Science ®Google Scholar
• Czikora I, Alli A, Bao HF, et al. A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. Am J Respir Crit Care Med. 2014;190(5):522–532.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354(24):2564–2575.
   PubMed Web of Science ®Google Scholar
• Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155–170.
   PubMed Web of Science ®Google Scholar
• Erstad BL, Gales BJ, Rappaport WD. The use of albumin in clinical practice. Arch Intern Med. 1991;151(5):901–911.
   PubMedGoogle Scholar
• Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–2256.
   PubMed Web of Science ®Google Scholar
• Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–1421.
   PubMed Web of Science ®Google Scholar
• Mårtensson J, Bihari S, Bannard-Smith J, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects: the SWIPE randomised clinical trial. Intensive Care Med. 2018;44(11):1797‐1806.
   Web of Science ®Google Scholar
• Sakuma T, Okaniwa G, Nakada T, et al. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med. 1994;150(2):305–310.
   PubMed Web of Science ®Google Scholar
• Maris NA, de Vos AF, Dessing MC, et al. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med. 2005;172(7):878–884.
   PubMed Web of Science ®Google Scholar
• O’Kane CM, McKeown SW, Perkins GD, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009;37(7):2242–2249.
   PubMed Web of Science ®Google Scholar
• Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax. 2008;63(3):215–220.
   PubMed Web of Science ®Google Scholar
• Gates S, Perkins GD, Lamb SE, et al. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome. Health Technol Assess. 2013;17(38):1–87.
   Web of Science ®Google Scholar
• Matthay MA, Brower RG, Carson S, et al. Randomized, placebo-controlled clinical trial of an aerosolized β2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;16(5):561–568.
   Google Scholar
• Willson DF, Notter RH. The future of exogenous surfactant therapy. Respir Care. 2011;56(9):1369–1388.
   PubMed Web of Science ®Google Scholar
• Echaide M, Autilio C, Arroyo R, et al. Restoring pulmonary surfactant membranes and films at the respiratory surface. Biochim Biophys Acta Biomembr. 2017;1859(9 Pt B):1725–1739.
   PubMed Web of Science ®Google Scholar
• Jin H, Ciechanowicz AK, Kaplan AR, et al. Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair. Am J Physiol Lung Cell Mol Physiol. 2018;314(5):L882–L892.
   PubMed Web of Science ®Google Scholar
• Meng SS, Chang W, Lu ZH, et al. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19(1):9.
   PubMedGoogle Scholar
• Meng H, Sun Y, Lu J, et al. Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials. J Cardiothorac Vasc Anesth. 2012;26(5):849–856.
   PubMed Web of Science ®Google Scholar
• Silva PL, Pelosi P, Rocco PRM. Personalized pharmacological therapy for ARDS: a light at the end of the tunnel. Expert Opin Investig Drugs. 2020;29(1):49–61.
   PubMed Web of Science ®Google Scholar
• Kodama T, Yukioka H, Kato T, et al. Neutrophil elastase as a predicting factor for development of acute lung injury. Intern Med. 2007;46(11):699–704.
   PubMed Web of Science ®Google Scholar
• Tamakuma S, Ogawa M, Aikawa N, et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther. 2004;17(5):271–279.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Jiang YW, Fang QH. Improving effect of Sivelestat on lipopolysaccharide-induced lung injury in rats. APMIS. 2014;122(9):810–817.
   PubMed Web of Science ®Google Scholar
• Zeiher BG, Artigas A, Vincent JL, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med. 2004;32(8):1695–1702.
   PubMed Web of Science ®Google Scholar
• Kido T, Muramatsu K, Yatera K, et al. Efficacy of early sivelestat administration on acute lung injury and acute respiratory distress syndrome. Respirology. 2017;22(4):708–713.
   PubMed Web of Science ®Google Scholar
• Pu S, Wang D, Liu D, et al. Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2017;17(1):148.
   PubMedGoogle Scholar
• Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med. 2010;49(22):2423–2432.
   PubMed Web of Science ®Google Scholar
• Hernández-Beeftink T, Guillen-Guio B, Villar J, et al. Genomics and the acute respiratory distress syndrome: current and future directions. Int J Mol Sci. 2019;20(16):4004.
   PubMed Web of Science ®Google Scholar
• Leligdowicz A. The challenge and the promise of identifying more homogeneous subgroups in acute respiratory distress syndrome. Crit Care Med. 2019;47(12):1806–1808.
   PubMed Web of Science ®Google Scholar
• Meyer NJ, Calfee CS. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir Med. 2017;5(6):512–523.
   PubMed Web of Science ®Google Scholar
• Sinha P, Calfee CS. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine. Curr Opin Crit Care. 2019;25(1):12–20.
   PubMed Web of Science ®Google Scholar
• Carla A, Pereira B, Boukail H, et al. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis. Respir Res. 2020;21(1):81.
   PubMed Web of Science ®Google Scholar
• Castela Forte J, Perner A, van der Horst ICC. The use of clustering algorithms in critical care research to unravel patient heterogeneity. Intensive Care Med. 2019;45(7):1025–1028.
   PubMed Web of Science ®Google Scholar